Phoxilium vs Hemosol-B0 for continuous renal replacement therapy in acute kidney injury

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 884.e7-884.e14

  Chua, Horng Ruey ^a,b   Schneider, Antoine G ^a   Baldwin, Ian ^a,c   Collins, Allison ^a   Ho, Lisa ^a   Bellomo, Rinaldo ^a,d  

^a AUSTIN HOSPITAL   (Australia)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c RMIT UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Acid base balance; Acute kidney injury; Continuous renal replacement therapy; Critical illness; Electrolyte abnormalities; Hemosol B0; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Metabolic acidosis; Nutrition; Phosphate containing solution; Phoxilium

Indexed keywords

BICARBONATE; CALCIUM ION; DIALYSIS FLUID; HEMOSOL B0; PHOXILIUM; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSATE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPHOSPHATEMIA; MALE; METABOLIC ACIDOSIS; PHOSPHATE BLOOD LEVEL;

ACID-BASE BALANCE; ACUTE KIDNEY INJURY; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICAL ILLNESS; ELECTROLYTE ABNORMALITIES; HEMOSOL-B0; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPHOSPHATEMIA; METABOLIC ACIDOSIS; NUTRITION; PHOSPHATE-CONTAINING SOLUTION; PHOXILIUM;

ACUTE KIDNEY INJURY; AGED; BLOOD SUBSTITUTES; CASE-CONTROL STUDIES; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; PHOSPHATES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84883559261     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.02.013     Document Type: Article

References (30)

1. Bellomo R., Ronco C. Continuous renal replacement therapy: continuous blood purification in the intensive care unit. Ann Acad Med Singapore 1998, 27(3):426-429.
2. Bellomo R., Ronco C. Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int Suppl 1998, 66:S125-S128.
3. Uchino S., Bellomo R., Morimatsu H., et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007, 33(9):1563-1570.
4. Ratanarat R., Brendolan A., Volker G., et al. Phosphate kinetics during different dialysis modalities. Blood Purif 2005, 23(1):83-90.
5. Kjellstrand C.M., Ing T.S., Kjellstrand P.T., et al. Phosphorus dynamics during hemodialysis. Hemodialysis international. Hemodial Int 2011, 15(2):226-233.
6. Tan H.K., Bellomo R., M'Pis D.A., et al. Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs 2001, 24(4):186-191.
7. Bellomo R., Cass A., Cole L., et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361(17):1627-1638.
8. Demirjian S., Teo B.W., Guzman J.A., et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011, 26(11):3508-3514.
9. Knochel J.P. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977, 137(2):203-220.
10. Jacob H.S., Amsden T. Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med 1971, 285(26):1446-1450.
11. Ognibene A., Ciniglio R., Greifenstein A., et al. Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia. South Med J 1994, 87(1):65-69.
12. Geerse D.A., Bindels A.J., Kuiper M.A., et al. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 2010, 14(4):R147.
13. Marik P.E., Bedigian M.K. Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study. Arch Surg 1996, 131(10):1043-1047.
14. Brooks G. Potassium additive algorithm for use in continuous renal replacement therapy. Nurs Crit Care 2006, 11(6):273-280.
15. Troyanov S., Geadah D., Ghannoum M., et al. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004, 30(8):1662-1665.
16. Bollaert P.E., Levy B., Nace L., et al. Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 1995, 107(6):1698-1701.
17. Treger R., Pirouz S., Kamangar N., et al. Agreement between central venous and arterial blood gas measurements in the intensive care unit. Clin J Am Soc Nephrol 2010, 5(3):390-394.
18. Stewart P.A. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983, 61(12):1444-1461.
19. Figge J., Mydosh T., Fencl V. Serum proteins and acid-base equilibria: a follow-up. J Lab Clin Med 1992, 120(5):713-719.
20. Zazzo J.F., Troche G., Ruel P., et al. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med 1995, 21(10):826-831.
21. Shor R., Halabe A., Rishver S., et al. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006, 36(1):67-72.
22. Brunelli S.M., Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol 2007, 18(7):1999-2003.
23. Broman M., Carlsson O., Friberg H., et al. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 2011, 55(1):39-45.
24. Santiago M.J., Lopez-Herce J., Urbano J., et al. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 2009, 75(3):312-316.
25. Amanzadeh J., Reilly R.F. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nature clinical practice. Nephrology 2006, 2(3):136-148.
26. Zhang M., Hsu R., Hsu C.Y., et al. FGF-23 and PTH levels in patients with acute kidney injury: a cross-sectional case series study. Ann Intensive Care 2011, 1(1):21.
27. Tamagaki K., Yuan Q., Ohkawa H., et al. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 2006, 21(3):651-659.
28. Bevington A., Brough D., Baker F.E., et al. Metabolic acidosis is a potent stimulus for cellular inorganic phosphate generation in uraemia. Clin Sci 1995, 88(4):405-412.
29. Shackney S., Hasson J. Precipitous fall in serum calcium, hypotension, and acute renal failure after intravenous phosphate therapy for hypercalcemia. Report of two cases. Ann Intern Med 1967, 66(5):906-916.
30. Winter R.J., Harris C.J., Phillips L.S., et al. Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 1979, 67(5):897-900.